NCT00810264

Brief Summary

The objective of this study is to confirm the long-term safety and reliability of the Corox OTW BP left ventricular (LV) pacing lead. As a condition of approval, the FDA required that a registry documenting the post approval clinical experience of these leads be designed and implemented.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,499

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2008

Longer than P75 for all trials

Geographic Reach
1 country

86 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2008

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

December 17, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 18, 2008

Completed
9.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 2, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 2, 2018

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

November 29, 2019

Completed
Last Updated

November 29, 2019

Status Verified

November 1, 2019

Enrollment Period

9.9 years

First QC Date

December 17, 2008

Results QC Date

October 8, 2019

Last Update Submit

November 11, 2019

Conditions

Keywords

Long-term safety and reliability of a bipolar left ventricular lead on congestive heart failure patients

Outcome Measures

Primary Outcomes (2)

  • Percentage of Subjects Who Are Free of Complications Related to the Corox LV Lead

    The overall incidence of serious adverse events that require additional invasive intervention to resolve, related to the Corox BP LV leads implanted with either BIOTRONIK CRT-P or CRT-D devices.This was evaluated as a serious adverse event free-rate (SAEFR).

    5 years

  • Percentage of Subjects Experiencing Individual Complications

    Evaluation of the individual types of serious adverse events contributing to primary outcome 1.

    5 years

Secondary Outcomes (10)

  • Mean Successful Biventricular Pacing in Subjects at the 5 Year In-office Visit.

    5 years

  • Percentage of Subjects Experiencing Serious Adverse Event Excluded From Primary Safety Endpoint

    5 years

  • Corox BP LV Lead Pacing Threshold Measurements

    5 years

  • Corox BP LV Lead Sensing Measurements

    5 years

  • Corox BP LV Lead Impedance Measurements

    5 years

  • +5 more secondary outcomes

Study Arms (1)

Data Collection Group

Device: CRT Therapy - LV Lead Registry

Interventions

Collecting long-term safety and efficacy data on a market-released left ventricular lead.

Data Collection Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients will be obtained from the investigators' general patient population according to the inclusion and exclusion criteria described below.

You may qualify if:

  • Successfully implanted BIOTRONIK CRT system, including a Corox BP LV lead, from 7-180 days prior to enrollment
  • Able to understand the nature of the registry and give informed consent
  • Available for follow-up visits on a regular basis at the investigational site
  • Age greater than or equal to 18 years

You may not qualify if:

  • Enrolled in any IDE clinical study
  • Planned cardiac surgical procedures or interventional measures within the next 6 months
  • Expected to receive a heart transplant within 1 year
  • Life expectancy less than 1 year
  • Presence of another life-threatening, underlying illness separate from their cardiac disorder
  • Pregnancy
  • Inability to provide date of implant, devices implanted, age, gender, and whether the patient experienced any protocol-defined adverse events since implant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (86)

Unknown Facility

Birmingham, Alabama, United States

Location

Unknown Facility

Glendale, Arizona, United States

Location

Unknown Facility

Mesa, Arizona, United States

Location

Unknown Facility

Phoenix, Arizona, United States

Location

Unknown Facility

Scottsdale, Arizona, United States

Location

Unknown Facility

Tucson, Arizona, United States

Location

Unknown Facility

Anaheim, California, United States

Location

Unknown Facility

Fairfield, California, United States

Location

Unknown Facility

Fountain Valley, California, United States

Location

Unknown Facility

Glendale, California, United States

Location

Unknown Facility

Hawthorne, California, United States

Location

Unknown Facility

Inglewood, California, United States

Location

Unknown Facility

Los Angeles, California, United States

Location

Unknown Facility

National City, California, United States

Location

Unknown Facility

Northridge, California, United States

Location

Unknown Facility

Orange, California, United States

Location

Unknown Facility

Rancho Mirage, California, United States

Location

Unknown Facility

Santa Barbara, California, United States

Location

Unknown Facility

Torrance, California, United States

Location

Unknown Facility

Ventura, California, United States

Location

Unknown Facility

Watsonville, California, United States

Location

Unknown Facility

Aurora, Colorado, United States

Location

Unknown Facility

Boulder, Colorado, United States

Location

Unknown Facility

Danbury, Connecticut, United States

Location

Unknown Facility

Brooksville, Florida, United States

Location

Unknown Facility

Davenport, Florida, United States

Location

Unknown Facility

Melbourne, Florida, United States

Location

Unknown Facility

Naples, Florida, United States

Location

Unknown Facility

New Smyrna Beach, Florida, United States

Location

Unknown Facility

St. Petersburg, Florida, United States

Location

Unknown Facility

Tampa, Florida, United States

Location

Unknown Facility

Macon, Georgia, United States

Location

Unknown Facility

Urbana, Illinois, United States

Location

Unknown Facility

Fort Wayne, Indiana, United States

Location

Unknown Facility

Valparaiso, Indiana, United States

Location

Unknown Facility

Owensboro, Kentucky, United States

Location

Unknown Facility

Covington, Louisiana, United States

Location

Unknown Facility

Hammond, Louisiana, United States

Location

Unknown Facility

Lafayette, Louisiana, United States

Location

Unknown Facility

Bangor, Maine, United States

Location

Unknown Facility

Baltimore, Maryland, United States

Location

Unknown Facility

Cumberland, Maryland, United States

Location

Unknown Facility

Lanham, Maryland, United States

Location

Unknown Facility

Rockville, Maryland, United States

Location

Unknown Facility

Burlington, Massachusetts, United States

Location

Unknown Facility

Worcester, Massachusetts, United States

Location

Unknown Facility

Ann Arbor, Michigan, United States

Location

Unknown Facility

Lansing, Michigan, United States

Location

Unknown Facility

Lapeer, Michigan, United States

Location

Unknown Facility

Saginaw, Michigan, United States

Location

Unknown Facility

Wyoming, Michigan, United States

Location

Unknown Facility

Ypsilanti, Michigan, United States

Location

Unknown Facility

Tupelo, Mississippi, United States

Location

Unknown Facility

Crystal City, Missouri, United States

Location

Unknown Facility

St Louis, Missouri, United States

Location

Unknown Facility

Las Vegas, Nevada, United States

Location

Unknown Facility

Glen Ridge, New Jersey, United States

Location

Unknown Facility

New York, New York, United States

Location

Unknown Facility

Rochester, New York, United States

Location

Unknown Facility

Gastonia, North Carolina, United States

Location

Unknown Facility

Winston-Salem, North Carolina, United States

Location

Unknown Facility

Columbus, Ohio, United States

Location

Unknown Facility

Middletown, Ohio, United States

Location

Unknown Facility

Steubenville, Ohio, United States

Location

Unknown Facility

Toledo, Ohio, United States

Location

Unknown Facility

Oklahoma City, Oklahoma, United States

Location

Unknown Facility

Salem, Oregon, United States

Location

Unknown Facility

Chinchilla, Pennsylvania, United States

Location

Unknown Facility

Lancaster, Pennsylvania, United States

Location

Unknown Facility

Philadelphia, Pennsylvania, United States

Location

Unknown Facility

Pottstown, Pennsylvania, United States

Location

Unknown Facility

Yardley, Pennsylvania, United States

Location

Unknown Facility

Columbia, South Carolina, United States

Location

Unknown Facility

Greenville, South Carolina, United States

Location

Unknown Facility

Spartanburg, South Carolina, United States

Location

Unknown Facility

Chattanooga, Tennessee, United States

Location

Unknown Facility

Amarillo, Texas, United States

Location

Unknown Facility

Brownsville, Texas, United States

Location

Unknown Facility

Corpus Christi, Texas, United States

Location

Unknown Facility

Dallas, Texas, United States

Location

Unknown Facility

Kingwood, Texas, United States

Location

Unknown Facility

McKinney, Texas, United States

Location

Unknown Facility

Nacogdoches, Texas, United States

Location

Unknown Facility

Fredericksburg, Virginia, United States

Location

Unknown Facility

Spokane, Washington, United States

Location

Unknown Facility

Yakima, Washington, United States

Location

Related Publications (1)

  • Good ED, Cakulev I, Orlov MV, Hirsh D, Simeles J, Mohr K, Moll P, Bloom H. Long-Term Evaluation of Biotronik Linox and Linox(smart) Implantable Cardioverter Defibrillator Leads. J Cardiovasc Electrophysiol. 2016 Jun;27(6):735-42. doi: 10.1111/jce.12971. Epub 2016 May 3.

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Results Point of Contact

Title
Clinical Studies Engineer Group Manager
Organization
BIOTRONIK

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 17, 2008

First Posted

December 18, 2008

Study Start

December 1, 2008

Primary Completion

November 2, 2018

Study Completion

November 2, 2018

Last Updated

November 29, 2019

Results First Posted

November 29, 2019

Record last verified: 2019-11

Locations